Carfilzomib in Kombination mit Daratumumab beim relapsierten/ refraktären Multiplen Myelom
Kurzvideo zur EQUULEUS (Phase 1b) und CANDOR (Phase 3) Studie
Kurzvideo zur EQUULEUS (Phase 1b) und CANDOR (Phase 3) Studie
You are now leaving oncologyhorizons.at
Amgen does not endorse or accept liability for sites controlled by third parties
You are now leaving oncologyhorizons.at
Amgen does not endorse or accept liability for sites controlled by third parties
You are now leaving oncologyhorizons.at
Amgen does not endorse or accept liability for sites controlled by third parties